If you are demanding any product or service please register as Farmavita.Net network member and publish your offer or demad.
In-Licensing and oursoucing of products is usual a way for development of winning portfolio of products. License-in is also very cost effective way of product/technology development.
Opportunities are listed according chronological order, the most recent first.
Company portfolio: Manufacturing over 100 products and +150 brands, catering to domestic and international markets. The formulations include Oral Liquid, Cephalosporin (Tablets, Capsule, Sachets and Dry Syrup), Cephalosporin (Dry powder injection), Small volume parenteral (Vials and Ampoules) and Lyophilized powder in vials. A cash-rich National Stock Exchange (NSE, Mumbai-India) listed organization from India, having strong entrepreneurship...
Objective: To enter into EU domain grabbing a regulatory compliant pharmaceutical manufacturing unit under running condition. The option can be high-end products as well as Nutraceutical manufacturing unit
Strategy: Purchase of few Marketing Authorizations relevant to EU region. Subsequent procurement of the products through contract sales, till manufacturing unit gets in place, selling the products to marketing arm, who should have strong...
Objective: To enter into EU domain procuring Marketing Authorizations for high-end products
Strategy: Purchase of few Marketing Authorizations relevant to EU region. Subsequent procurement of the products through contract sales, till manufacturing unit gets in place, selling the products to marketing arm, who should have strong presence in the region, and may act as a business partner as well (JV), with or without equity...
Unique supplement products is needed for in-licensing with or without supply, kindly contact me with your offer and details. Thanks.
OTC Sachet & Granules dosage form is needed for in-licensing with or without supply, kindly contact me with your offer and details. Thanks.
OTC medical device products (preferably CE) is needed for in-licensing with or without supply, kindly contact me with your offer and details. Thanks.
Lokking for EU CTD Dossiers for traditional herbal pharmaceuticals, without supply.
Looking for OTC medications against acne
Farmavita.Net member is looking for OTC medicatios against acne. Product should be approved in EU and have up-to-date CTD Dossier. Licensee will also close exclusive supply agreement with licensor.
In-license teritory is south-east Europe. Please contact us at firstname.lastname@example.org for more details.
Agency and distribution partership for branded medicines in China
Farmavita.Net member is looking for long-term agency and distribution partership of branded anticancer or cardiovascular medicines in China. Neptunus Group was established in 1989, and now it has been one of the famous brands of the health industry in China, the comprehensive competitiveness of which ranks the top in the pharmaceutical industry in China.
Comapny is mainly...
License in Demand for Veterinary Medicines
Company focused on animal health, established at market of southeast Europe, Ukraine and Belarus is looking for Dossier with 3 years supply for Florfenicol - Florfenicol solution - Linkospectin premix and Fipronil spot on.
Member is looking for:
- Florfenicol premix a 1 kg - Florfenicol solution a 1 L - Linkospectin premix - Fipronil spot on
Dossier should be in European format. Tree year...
Member of Farmavita.Net from Columbia is seeking...
Member of Farmavita.Net from Columbia is seeking Fosfomycin 1 and 4g (for IV injection). This product needs to be registered and the requirement of fulfilling Zone IV stability studies is mandatory. Registration approval can be received with 6 months accelerated stability test (for Zone IV) completed.
The estimate sales for the first year is about 10000 units (90% in the 4g presentation), the growth estimate is about 15-20%/year
Demand for Prolonged-release formulation of Orlistat
The "TOP 10 Global Pharma Company" is seeking:
Once a day Orlistat dosing formulation in solid oral dose that would stay in the intestine and release drug for up to 24 hours in response to physiological changes associated with eating.
They are looking for potential partners with unique innovative technologies to meet changing needs of global consumers. Seeker is the leading...
Demand for Oral nicotine formulation with immediate fast release
The "TOP 10 Global Pharma Company" is seeking:
Oral nicotine formulation that provides immediate fast release of nicotine and then a steady release over typical consumption period.
They are looking for potential partners with unique innovative technologies to meet changing needs of global consumers. Seeker is the leading research-based pharmaceutical and healthcare company...
Looking for MONTELUKAST 4-mg oral granules
Registered user of Farmavita.Net is looking for EU CTD Dossier with supply for MONTELUKAST, 4-mg oral granules. Product is sought for non-EU markets, where data exclusivity and patents are not in force.
Montelukast (trade name Singulair) is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. It is usually...
License-in Demand for Mometasone Nasal Spray
Member of Farmavita.Net require full EU dossier in CTD format including supply for Mometasone nasal spray 0,05 mg/doses, for territory NL.
Demand for Lansoprazole 15mg – 30 mg tablets
Member of Farmavita.Net is looking for license for use of EU CTD Dossier for Lansoprasole disintegrating tablets of 15mg - 30 mg, with supply of bulk blisters. License-in territory is Poland.
Products suitable for MA transfer or MRP will have priority.
Forecast of demand is:
0,03 g x14...
License-in Demand for Ketoprofen Sustain-Release
Member of Farrmavita.Net require ketoprofen sustain-release 100-200 mg caps, dossier CTD + supply of finish goods, with posibility of registration in EU with MRP/DC.
Looking for Glatiramer, injections 20...
License demand for Furbiprofen 200 mg SR
Client of Farmavita.Net is looking for CTD Dossier with bulk supply of furbiprofen 200 mg, extended release formulation.
License-in territory: worldwide.